Eterna Therapeutics
ERNA
#11171
Rank
โ‚น0.21 B
Marketcap
โ‚น126.02
Share price
-16.56%
Change (1 day)
4.19%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -โ‚น2,608

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น2,714. In 2022 the company made an earnings per share (EPS) of -โ‚น2,91,532 an increase over its 2021 EPS that were of -โ‚น19,26,054.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,608
2022-โ‚น2,91,532-84.86%
2021-โ‚น19,26,054

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น183.52-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น130.65-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚น158.45-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น7.41-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น108.41-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA